BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1097513)

  • 1. Cytotoxic activity of lymphocytes. V. Role of soluble toxin in macrophage-inhibited cultures of tumor cells.
    Reed WP; Lucas ZJ
    J Immunol; 1975 Aug; 115(2):395-404. PubMed ID: 1097513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activity of lymphocytes. II. Studies on mechanism of lymphotoxin-mediated cytotoxicity.
    Walker SM; Lucas ZJ
    J Immunol; 1972 Dec; 109(6):1233-44. PubMed ID: 5086236
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxicity mediated by soluble macrophage product(s).
    Sethi KK; Brandis H
    J Natl Cancer Inst; 1975 Aug; 55(2):393-5. PubMed ID: 808640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat macrophage-mediated toxicity to cancer cells; effect of endotoxins and endotoxin inhibitors contained in culture media.
    Martin F; Martin M; Jeannin JF; Lagneau A
    Eur J Immunol; 1978 Aug; 8(8):607-11. PubMed ID: 699956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target cell destruction in vitro by concanavalin A-stimulated lymphoid cells.
    Schwartz HJ; Wilson F
    Am J Pathol; 1971 Aug; 64(2):295-304. PubMed ID: 5142268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
    Piessens WF; Churchill WH; David
    J Immunol; 1975 Jan; 114(1 Pt 2):293-9. PubMed ID: 163856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat lung macrophage tumor cytotoxin production: impairment by chronic in vivo cigarette smoke exposure.
    Flick DA; Gonzalez-Rothi RJ; Harris JO; Gifford GE
    Cancer Res; 1985 Nov; 45(11 Pt 1):5225-9. PubMed ID: 2413988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis and necrosis: analysis of two cytotoxic phenomena mediated by lymphocytes.
    Ginsburg H; Naot Y; Hollander N
    Isr J Med Sci; 1976; 12(4-5):435-53. PubMed ID: 59715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
    Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer-helper effect of L cells in the generation of anti-MM cytotoxic T lymphocytes: replacement by beta-interferon and mechanisms of action.
    Ishikawa S; Tachibana T
    Jpn J Cancer Res; 1986 Sep; 77(9):931-40. PubMed ID: 2945807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of target cell destruction by alloimmune peritoneal macrophages. II. Release of a specific cytotoxin from interacting cells.
    McIvor KL; Weiser RS
    Immunology; 1971 Mar; 20(3):315-22. PubMed ID: 5102519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of human lymphotoxin.
    Russell SW; Rosenau W; Goldberg ML; Kunitomi G
    J Immunol; 1972 Oct; 109(4):784-90. PubMed ID: 5074332
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of macrophage-like characteristics in a cultured murine tumor line.
    Koren HS; Handwerger BS; Wunderlich JR
    J Immunol; 1975 Feb; 114(2 pt 2):894-7. PubMed ID: 1167564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supernatants from ethanol-containing macrophage cultures have cytotoxic activity.
    Wickramasinghe SN
    Alcohol Alcohol; 1986; 21(3):263-8. PubMed ID: 3464283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple photometric microassay for the quantitative evaluation of macrophage-mediated cytotoxicity on adherent cancer cells.
    Olsson NO; Leclerc A; Jeannin JF; Martin F
    Ann Immunol (Paris); 1982; 133D(3):245-54. PubMed ID: 7165278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.